Internal Medicine, Endocrinology, Diabetes, & Metabolism · Daly City, CA
NPI
1669600086
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
386 Gellert Blvd
Daly City, CA, 94015
Phone (650) 761-3500
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
1,951 services
Medicare patients, 2024
134
Average age 76
Drug cost, 2024
$3.2M
5,340 prescriptions
Company payments, 2025
$171
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chengyu Xu was code J0897 (injection, denosumab, 1 mg), 1,380 times for 18 patients. In total Chengyu Xu billed 1,951 services in 18 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 18 | $0.94 | $1,291 |
| 99214 Office E&M - Established | Office | 208 | 108 | $102.15 | $21K |
| 82962 Clinical Chemistry | Office | 130 | 70 | $3.21 | $417 |
| 83037 Blood Count | Office | 127 | 69 | $9.52 | $1,209 |
| 96372 Injection Administration | Office | 29 | 20 | $12.68 | $368 |
| 95251 Test - Miscellaneous | Office | 26 | 12 | $31.03 | $807 |
| 99204 Office E&M - New | Office | 20 | 20 | $147.50 | $2,950 |
By year: 2022 $33K for 2,275 services; 2023 $35K for 2,497 services; 2024 $30K for 1,951 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 130 | 70 | $3.21 | $417 |
| 83037 Blood Count | 127 | 69 | $9.52 | $1,209 |
Medicare prescription drug claims, 2024
In 2024, the drug Chengyu Xu prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 593 prescriptions and refills. In total Chengyu Xu wrote 5,340 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 593 | 1,630 | 181 | $848K |
| Metformin Hcl Generic | 590 | 1,765 | 201 | $5,070 |
| Farxiga Dapagliflozin Propanediol | 365 | 995 | 123 | $525K |
| Levothyroxine Sodium Generic | 315 | 955 | 101 | $4,532 |
| Tradjenta Linagliptin | 230 | 648 | 67 | $308K |
| Ulticare Pen Needle Pen Needle, Diabetic | 178 | 516 | 69 | $21K |
| Methimazole Generic | 166 | 509 | 68 | $2,770 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 158 | 455 | 48 | $90K |
| Pioglitazone Hcl Generic | 147 | 441 | 52 | $2,181 |
| Insulin Aspart Flexpen Insulin Aspart | 145 | 395 | 48 | $44K |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 138 | 411 | 78 | $314 |
| Glipizide Generic | 137 | 406 | 48 | $1,139 |
| Rybelsus Semaglutide | 123 | 345 | 36 | $308K |
| Trulicity Dulaglutide | 113 | 275 | 28 | $262K |
| Prolia Denosumab | 110 | 633 | 68 | $175K |
Brand drugs: 2,759 claims; generic drugs: 1,916 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chengyu Xu $171 ($171 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $171.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 3 | $171 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.